Loading...
GoodRx Holdings, Inc.
GDRX•NASDAQ
Healthcare
Medical - Healthcare Information Services
$5.00
$0.03(0.60%)
GoodRx Holdings, Inc. (GDRX) Financial Performance & Income Statement Overview
Review GoodRx Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.61%
↑ 5.61%
Operating Income Growth
343.81%
↑ 343.81%
Net Income Growth
284.82%
↑ 284.82%
Operating Cash Flow Growth
32.97%
↑ 32.97%
Operating Margin
10.36%
↑ 10.36%
Gross Margin
91.71%
↑ 91.71%
Net Profit Margin
6.02%
↑ 6.02%
ROE
6.99%
↑ 6.99%
ROIC
6.93%
↑ 6.93%
GoodRx Holdings, Inc. (GDRX) Income Statement & Financial Overview
Review GoodRx Holdings, Inc.'s (GDRX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $198.58M | $195.25M | $200.61M | $197.88M |
| Cost of Revenue | $12.19M | $11.68M | $28.84M | $28.41M |
| Gross Profit | $186.39M | $183.57M | $171.78M | $169.47M |
| Gross Profit Ratio | $0.94 | $0.94 | $0.86 | $0.86 |
| R&D Expenses | $31.74M | $30.14M | $30.85M | $31.02M |
| SG&A Expenses | $117.38M | $115.49M | $120.30M | $118.02M |
| Operating Expenses | $168.21M | $163.16M | $151.16M | $149.04M |
| Total Costs & Expenses | $180.40M | $174.84M | $179.99M | $177.45M |
| Interest Income | $4.59M | $4.80M | $6.33M | $7.55M |
| Interest Expense | $11.36M | $12.36M | $14.57M | $14.64M |
| Depreciation & Amortization | $19.10M | $17.54M | $16.96M | $15.94M |
| EBITDA | $41.86M | $38.002M | $36.84M | $36.32M |
| EBITDA Ratio | $0.21 | $0.19 | $0.18 | $0.18 |
| Operating Income | $18.18M | $20.41M | $20.62M | $20.43M |
| Operating Income Ratio | $0.09 | $0.10 | $0.10 | $0.10 |
| Other Income/Expenses (Net) | -$6.77M | -$12.29M | -$8.23M | -$20.14M |
| Income Before Tax | $11.41M | $8.11M | $11.65M | $293000.00 |
| Income Before Tax Ratio | $0.06 | $0.04 | $0.06 | $0.001 |
| Income Tax Expense | $4.67M | $4.15M | $4.95M | $1.30M |
| Net Income | $6.74M | $12.26M | $6.69M | -$1.009M |
| Net Income Ratio | $0.03 | $0.06 | $0.03 | -$0.005 |
| EPS | $0.02 | $0.03 | $0.02 | -$0.003 |
| Diluted EPS | $0.02 | $0.03 | $0.02 | -$0.003 |
| Weighted Avg Shares Outstanding | $381.61M | $379.67M | $376.25M | $390.05M |
| Weighted Avg Shares Outstanding (Diluted) | $383.58M | $388.50M | $384.73M | $390.05M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan